(Q79928187)

English

Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop

scientific article published on 01 June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

8

object named as

P Gaynon

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

C-H Pui

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M Schrappe

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

G Masera

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

J Nachman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

H Gadner

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

O B Eden

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

W E Evans

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ponte di Legno Working Group

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 June 2004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1043-1053

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15085155%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403365

0 references

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

International collaboration on childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

'Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April - 1 May 2002.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease-based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

AML1 gene over-expression in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent research advances in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Origins of chromosome translocations in childhood leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease in leukaemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Childhood acute lymphoblastic leukaemia--current status and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of antileukemia effects of allogeneic NK cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

MLL-rearranged leukemias: insights from gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

FLT3: ITDoes matter in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403365

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79928187&oldid=2075687064"